Lenacapavir: a new treatment of resistant HIV-1 infections
Lancet Infect Dis
.
2023 Mar;23(3):286.
doi: 10.1016/S1473-3099(23)00075-0.
Authors
Ammara Mushtaq
,
Farooq Kazi
PMID:
36841248
DOI:
10.1016/S1473-3099(23)00075-0
No abstract available
MeSH terms
Anti-HIV Agents* / therapeutic use
HIV Infections* / drug therapy
HIV-1*
Humans
Substances
Anti-HIV Agents